ATE225808T1 - Ligand fähig zur bindung an der adenosinedeaminase-bindungsstelle von cd26 - Google Patents

Ligand fähig zur bindung an der adenosinedeaminase-bindungsstelle von cd26

Info

Publication number
ATE225808T1
ATE225808T1 AT95900671T AT95900671T ATE225808T1 AT E225808 T1 ATE225808 T1 AT E225808T1 AT 95900671 T AT95900671 T AT 95900671T AT 95900671 T AT95900671 T AT 95900671T AT E225808 T1 ATE225808 T1 AT E225808T1
Authority
AT
Austria
Prior art keywords
binding
functional derivative
ligand
adenosinedeaminase
immuno
Prior art date
Application number
AT95900671T
Other languages
English (en)
Inventor
Meester Ingrid De
Ham Guido Van
Luc Kestens
Greta Vanhoof
Peggy Verhelst
Filip Goossens
Dirk Hendriks
Marianne Borloo
Achiel Haemers
Eugene Bosmans
Simon Scharpe
Original Assignee
Eurogenetics Nv
Universitaire Instelling Antwe
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurogenetics Nv, Universitaire Instelling Antwe filed Critical Eurogenetics Nv
Application granted granted Critical
Publication of ATE225808T1 publication Critical patent/ATE225808T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95900671T 1993-11-04 1994-11-04 Ligand fähig zur bindung an der adenosinedeaminase-bindungsstelle von cd26 ATE225808T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93203093 1993-11-04
NL9400309A NL9400309A (nl) 1993-11-04 1994-02-28 Ligande die in staat is te binden aan de adenosine deaminase bindingsplaats van CD26.
PCT/EP1994/003632 WO1995012618A1 (en) 1993-11-04 1994-11-04 A ligand capable of binding to the adenosine deaminase binding-site of cd26

Publications (1)

Publication Number Publication Date
ATE225808T1 true ATE225808T1 (de) 2002-10-15

Family

ID=8214159

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95900671T ATE225808T1 (de) 1993-11-04 1994-11-04 Ligand fähig zur bindung an der adenosinedeaminase-bindungsstelle von cd26

Country Status (9)

Country Link
EP (2) EP0726915B1 (de)
AT (1) ATE225808T1 (de)
AU (1) AU8140494A (de)
DE (1) DE69431526T2 (de)
DK (1) DK0726915T3 (de)
ES (1) ES2180619T3 (de)
NL (1) NL9400309A (de)
PT (1) PT726915E (de)
WO (1) WO1995012618A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825169B1 (en) 1991-10-22 2004-11-30 Trustees Of Tufts College Inhibitors of dipeptidyl-aminopeptidase type IV
AU6280296A (en) * 1995-06-16 1997-01-15 Enzon, Inc. Method of treating cd4+ t cell lymphopenia in immuno-compromised patients
US5728560A (en) * 1996-06-14 1998-03-17 Enzon, Inc. Method of treating CD4+ T cell lymphopenia in immuno-compromised patients
US5965532A (en) 1996-06-28 1999-10-12 Trustees Of Tufts College Multivalent compounds for crosslinking receptors and uses thereof
US6040145A (en) 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
BR9813233A (pt) 1997-09-29 2000-08-22 Point Therapeutics Inc Estimulação de células hematopoéticas in vitro
JP2002513762A (ja) 1998-05-04 2002-05-14 ポイント セラピューティクス， インコーポレイテッド 造血刺激
BR9910907A (pt) 1998-06-05 2002-02-13 Point Therapeutics Inc Compostos cìclicos de boroprolina
US6979697B1 (en) 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US11242399B2 (en) 2013-02-19 2022-02-08 Adienne S.A. Anti-CD26 antibodies
EP2767549A1 (de) 2013-02-19 2014-08-20 Adienne S.A. Anti-CD26-Antikörper und Verwendungen davon
TWI677505B (zh) * 2014-08-18 2019-11-21 瑞士商艾迪安納股份有限公司 抗ｃｄ２６抗體及其用途

Also Published As

Publication number Publication date
DK0726915T3 (da) 2003-02-17
PT726915E (pt) 2003-02-28
ES2180619T3 (es) 2003-02-16
NL9400309A (nl) 1995-06-01
EP1179542A1 (de) 2002-02-13
DE69431526T2 (de) 2003-07-10
EP0726915B1 (de) 2002-10-09
AU8140494A (en) 1995-05-23
WO1995012618A1 (en) 1995-05-11
DE69431526D1 (de) 2002-11-14
EP0726915A1 (de) 1996-08-21

Similar Documents

Publication Publication Date Title
ATE225808T1 (de) Ligand fähig zur bindung an der adenosinedeaminase-bindungsstelle von cd26
DE3588210D1 (de) Biologisch nützliche Konjugate
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
DE3766157D1 (de) Kupplungsmittel zum radiomarkieren von proteinen.
ES2067604T3 (es) Anticuerpos frente a proteina que se une a tnf i y a sus fragmentos f(ab).
DE69433285D1 (de) Hepatitis-b-virusmutanten, und verbindungen und verfahren für ihre bestimmung
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
ES2141086T3 (es) Anticuerpos contra los ligando-analogos y su uso en los dosificados ligando-receptores.
DE69122282D1 (de) Komplexe und Chelate des Azithromycins als Antiulcus-Mittel
SE9003571L (sv) Ljuddaempare foer motorfordon
IL93207A0 (en) A monoclonal antibody which binds to factor betaxiia and shows no substantial binding to factor xii
DE69114184D1 (de) Harzzusammensetzung für Grundierung und Grundierungsmittel davon.
EE03783B1 (et) Farmatseutiline kompositsioon epitelioomide raviks ja antikeha või antikeha molekuli kasutamine
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
EP0745222A4 (de) Tests für kompetitive bindung mit verbesserter linearität
FI963638L (fi) Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
ES2082132T3 (es) Composicion que contiene al menos dos anticuerpos distintos o fragmentos de ellos.
FI903705A7 (fi) Putken ja kellukkeen välisen raon mittaaminen
TR199600117A2 (tr) Ikame edilen benzolsülfonilüre ve tiyoüre, bu maddelerin elde edilmesi ve eczanecilikle ilgili maddelerin bu bilesimler ve bu bilesimleri iceren iyilestirici maddelere dayanarak kullanilmasi ile ilgili usul.
FI913128A7 (fi) Koostumus keskitisleiden kylmävirtausominaisuuksien parantamiseksi
DE69022795D1 (de) Nachweis eines Antikörpers und dessen Immunglobulin-Klasse.
NO913293L (no) Komponenter til motorer og kjoeretoey.
OA08559A (fr) Anticorps monoclonaux à réactivité et à protectivité croisées vis-à-vis des sérotypes de P. Aeruginosa.
ATE118032T1 (de) Monoklonale antikörper und diagnoseverfahren für phytophthora-infektionen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0726915

Country of ref document: EP

REN Ceased due to non-payment of the annual fee